The health services management company, founded by UPMC Health Plan and The Advisory Board Company, has targeted $100m for its initial public offering.

The cancer therapeutics developer, backed by Novo and Immunocore, raised the cash less than a year after closing a nine-figure series A round.

The newly formed pharmaceutical company, backed by investors including Novo, also raised $40m to advance its lead product through clinical trials.

Recruit took an 80% stake in the hair and beauty marketplace, buying out all other investors for $171m, and provided $46m in series D funding for Wahanda's expansion.

CEO Rahul Sood confirmed Tabcorp's investment in the eSports startup, which launched its platform in partnership with the gambling business this week.

The settlement in a long-running legal battle with nine record companies has led the Intel-backed music service to close down.

Singapore Telecommunications has exited travel e-commerce company Flocations, which raised almost $600,000 in 2012, through an acquisition by Venture Republic Group.

The Google-backed anonymous social network is set to close after securing 15 million users, $35m of venture funding and a valuation of more than $100m.

Shareholder Johnson & Johnson bought stock in the molecular diagnostics technology provider as it floated in Brussels at a valuation of more than $500m.

Ligand acquired a 37% share in the biopharmaceutical company, which is set to float on Nasdaq, issuing three million shares priced at $8.00 each.